• Biotron Drug Effective Against COVID-19 In Animals prnewswire
    November 26, 2021
    The Directors of Biotron Limited (ASX: BIT) are pleased to announce that the Company's lead clinical asset, BIT225, has demonstrated substantial and clinically meaningful efficacy against SARS-CoV-2 in a series...
PharmaSources Customer Service